Standard Biotools Inc (LAB) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Standard Biotools Inc   (NASDAQ: LAB)
 

Standard Biotools Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Standard Biotools Inc inventory turnover ratio, the Standard Biotools Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.02 in the second quarter 2026, LAB's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Standard Biotools Inc in Jun 30 2026 quarter, has decreased to 181 days, compare to 190 days, in the Mar 31 2026 quarter.

Within Healthcare sector 202 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1482 in the first quarter 2026, to 1769.

LAB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Standard Biotools Inc Market Share?

What is Inventory Turnover Ratio?




LAB Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -29.24 % -55.86 % -3.68 % -40.39 % -43.29 %
Y / Y Cost of Sales Growth -13.01 % -1.89 % -52.26 % 0.4 % -9.23 %
Inventory Turnover Ratio (TTM) 2.02 1.92 1.53 2 1.73
LAB's Total Ranking # 1769 # 1482 # 1389 # 968 # 1259
Average inventory processing period 181 190 239 183 211
Seq. Inventory Growth -8.02 % -6.94 % -21.39 % 5.16 % -42.62 %
Seq. Cost of Sales Growth 6.32 % -27.5 % 24.13 % -9.09 % 19.92 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 203
Overall Market # 1769

Inventory Turnover Ratio Statistics
High Average Low
3.72 2.01 0.2
(Dec 31 2019)   (Dec 31 2015)




Financial Statements
Standard Biotools Inc 's Inventories $ 17 Millions Visit LAB's Balance sheet
Standard Biotools Inc 's Cost of Revenues TTM $ 41 Millions Visit LAB's Income Statement
What are LAB's Sales? Visit LAB's Sales by Segment

Other Inventory Turnover Ratios
Standard Biotools Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LAB's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LAB's Competitors
Inventory Turnover Ratio for LAB's Suppliers
Inventory Turnover Ratio for LAB's Customers

You may also want to know
LAB's Sales Growth Rates LAB's Pe Price to earnings ratio LAB's Receivables Turnover Ratio LAB's Stock Quote
LAB's Net Income Growth Rates LAB's Ps Price to Sales ratio LAB's Sales per Employee LAB's Asset Turnover Ratio
LAB's Net Margin LAB's Pb Price to Book ratio LAB's Financial Strength Ratios LAB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Edap Tms Sa  6.05 $ 60.703  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions

Date modified: 2026-09-01T20:00:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.